1-3 of 3
Yazan F. Madanat
Close
Save search
Sort by
Journal Articles

Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Free
Fieke W. Hoff, William G. Blum, Ying Huang, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Kellie J. Archer, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca L. Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K. Curran, Kristin L. Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, John C. Byrd, Yazan F. Madanat
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5297–5305.
https://doi.org/10.1182/bloodadvances.2024013685
Published: 2024
Includes: Supplemental data
Journal Articles

Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

Free
Clinical Trials & Observations
Courtney D. DiNardo, Gail J. Roboz, Justin M. Watts, Yazan F. Madanat, Gabrielle T. Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M. Foran, Martha L. Arellano, David A. Sallman, Mohammad Hossain, Dylan M. Marchione, Xiaofei Bai, Prapti A. Patel, Stephanie M. Kapsalis, Guillermo Garcia-Manero, Amir T. Fathi
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4209–4220.
https://doi.org/10.1182/bloodadvances.2023012302
Published: 2024
Includes: Supplemental data
Journal Articles

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Free
Clinical Trials & Observations
Olga K. Weinberg, Alexa Siddon, Yazan F. Madanat, Jeffrey Gagan, Daniel A. Arber, Paola Dal Cin, Damodaran Narayanan, Madhu M. Ouseph, Jason H. Kurzer, Robert P. Hasserjian
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2847–2853.
https://doi.org/10.1182/bloodadvances.2021006239
Published: 2022
Includes: Supplemental data